Organization
Shanghai Synergy Pharmaceutical Sciences
2 clinical trials
Clinical trial
A Single-center, Open-label, Single-dose Ascending Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of HHT201 (Donepezil Dihydroxynaphthalate for Injection) in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
A Single and Multiple Assending Doses Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic Characteristics and Food Effect After Administration of HHT120 Capsule in Healthy SubjectsStatus: Withdrawn, Estimated PCD: 2023-02-15